コネクテッドドラッグデリバリー市場：製品、技術、治療領域、流通チャネル、エンドユーザー別-2025～2030年の世界予測

コネクテッドドラッグデリバリー市場は、2023年に8億5,317万米ドルと評価され、2024年には9億6,622万米ドルに達すると予測され、CAGR 14.45%で成長し、2030年には21億9,537万米ドルに達すると予測されています。

コネクテッドドラッグデリバリーは、患者の服薬アドヒアランスと治療結果に関するリアルタイムのモニタリングとデータ収集を可能にすると同時に、薬剤の投与を可能にする高度な医療機器を指します。個別化ヘルスケア、患者中心の治療モデル、医療技術におけるIoTの統合に対する需要の高まりにより、この範囲はますます不可欠となっています。これらのデバイスは、コネクテッドインスリンペンを使った糖尿病管理、スマート吸入器を使った喘息治療、ウェアラブル注射器を使った腫瘍治療など、慢性疾患管理全体に大きな応用が見られます。病院、在宅介護の現場、外来患者施設が主な最終用途となり、患者のコンプライアンスを大幅に向上させ、遠隔監視を可能にします。

同市場は、慢性疾患の増加、デジタルヘルスの技術進歩、ヘルスケアコストの削減重視の高まりといった要因の影響を受けています。最新のビジネスチャンスは、患者の洞察力を向上させるためのAI主導型アナリティクスの開発、デバイスの相互運用性の強化、新たな健康問題への応用の拡大にあります。企業は、データ分析を活用し、デバイスのアクセシビリティを向上させるために、ハイテク企業やヘルスケアプロバイダーとのパートナーシップに投資することが推奨されます。

しかし、高い開発コスト、データ・プライバシーの問題、規制上のハードルといった課題が成長を阻害する可能性があります。また、一部の患者集団やヘルスケア専門家による技術導入への抵抗感や、機器の信頼性や寿命に対する懸念も、市場浸透の妨げとなっています。技術革新は、これらの機器の精度と統合機能の向上、より正確な投与と患者フィードバックループを保証する適応アルゴリズムの開発に焦点を当てるべきです。

さらに、患者データを保護するためのサイバーセキュリティ対策も重要です。小型化とバッテリー寿命の延長における革新が、競合他社との差別化を促進する可能性があります。同市場は技術進化のペースが速いという特徴があり、利害関係者には継続的な適応と回復力が求められます。このダイナミックな市場で持続的な成長軌道を維持するには、患者のニーズ、規制状況、技術の進歩を理解することが不可欠です。

市場力学：急速に進化するコネクテッドドラッグデリバリー市場の主要市場インサイトを公開

コネクテッドドラッグデリバリー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患・障害の増加
  • コネクテッドドラッグデリバリーに対する規制当局の支持的承認
  • 多様な背景を持つ患者のヘルスケアソリューションへのアクセスを改善するための政府の支援政策
• 市場抑制要因
  • コネクテッドドラッグデリバリーの正確性と有効性における複雑性
• 市場機会
  • コネクテッドドラッグデリバリーの安全性と機能性を向上させるための継続的な技術革新
  • 個別化医療へのコネクテッドドラッグデリバリー採用の可能性
• 市場の課題
  • コネクテッドドラッグデリバリーの使用に伴うプライバシーやデータセキュリティの問題

ポーターの5つの力：コネクテッドドラッグデリバリー市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、コネクテッドドラッグデリバリー市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コネクテッドドラッグデリバリー市場における外部からの影響の把握

外部マクロ環境要因は、コネクテッドドラッグデリバリー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コネクテッドドラッグデリバリー市場における競合情勢の把握

コネクテッドドラッグデリバリー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコネクテッドドラッグデリバリー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コネクテッドドラッグデリバリー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨コネクテッドドラッグデリバリー市場における成功への道筋を描く

コネクテッドドラッグデリバリー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患や障害の発生率が上昇
    • コネクテッドドラッグデリバリーの規制承認の支援
    • 多様な背景を持つ患者がヘルスケアソリューションにアクセスしやすくするための政府の支援政策
  • 抑制要因
    • コネクテッドドラッグデリバリーの正確性と有効性の複雑さ
  • 機会
    • コネクテッドドラッグデリバリーの安全性と機能性を向上させるための継続的な革新
    • 個別化医療におけるコネクテッドドラッグデリバリーの導入の可能性
  • 課題
    • コネクテッドドラッグデリバリーの使用に関連するプライバシーの懸念とデータセキュリティの問題
• 市場セグメンテーション分析
  • 製品：スマート吸入器の新たな進歩と革新
  • 治療領域：呼吸器疾患のリアルタイムモニタリングを容易にするためのコネクテッドドラッグデリバリーの必要性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 コネクテッドドラッグデリバリー市場：製品別

• 接続された注射装置
• スマート吸入器
• スマートピル

第7章 コネクテッドドラッグデリバリー市場：技術別

• Bluetooth
• 近距離無線通信
• Wi-Fi

第8章 コネクテッドドラッグデリバリー市場治療領域別

• 心血管疾患
• 糖尿病
• 神経学
• 呼吸器疾患

第9章 コネクテッドドラッグデリバリー市場：流通チャネル別

• 病院と臨床薬局
• オンラインプラットフォーム
• 薬局

第10章 コネクテッドドラッグデリバリー市場：エンドユーザー別

• ホームケア設定
• 病院・クリニック
• 研究開発センター

第11章 南北アメリカのコネクテッドドラッグデリバリー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のコネクテッドドラッグデリバリー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのコネクテッドドラッグデリバリー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アプターデジタルヘルスとSHLメディカルが協力し、自己注射型ドラッグデリバリーデバイスで患者体験を向上
  • アヘリウムのスマート吸入器がアストラゼネカのデバイスでの使用を承認され、コネクテッドドラッグデリバリーを強化
  • 新しいパートナーシップにより、喘息とCOPDの個別ケアのためのスマートデバイスが発売
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Adherium Limited
• AptarGroup, Inc.
• Becton, Dickinson, and Company
• Cognita Labs LLC
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Findair Sp. z o. o.
• Gerresheimer AG
• Medtronic PLC
• Merck KGaA
• Molex LLC
• Novartis AG
• Novo Nordisk A/S
• OPKO Health, Inc.
• Otsuka America, Inc.
• Presspart Verwaltungs-GmbH
• ResMed Inc.
• SHL Medical AG
• Sulzer Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• West Pharmaceutical Services, Inc.
• Ypsomed Holding
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. CONNECTED DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONNECTED DRUG DELIVERY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CONNECTED INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEAR FIELD COMMUNICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 74. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 79. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 165. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 185. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 190. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Connected Drug Delivery Devices Market was valued at USD 853.17 million in 2023, expected to reach USD 966.22 million in 2024, and is projected to grow at a CAGR of 14.45%, to USD 2,195.37 million by 2030.

Connected Drug Delivery Devices refer to advanced medical devices that allow for the administration of medication while simultaneously enabling real-time monitoring and data collection concerning a patient's adherence and therapeutic outcomes. This scope is increasingly essential due to rising demands for personalized healthcare, patient-centric treatment models, and the integration of IoT in medical technologies. These devices find substantial application across chronic disease management, including diabetes management through connected insulin pens, asthma care via smart inhalers, and oncology treatments using wearable injectors. Hospitals, home care settings, and outpatient facilities constitute the primary end-use landscapes, significantly enhancing patient compliance and enabling remote monitoring.

The market is influenced by factors such as the increasing prevalence of chronic diseases, technological advancements in digital health, and a growing emphasis on reducing healthcare costs. Latest opportunities lie in developing AI-driven analytics for improved patient insights, enhancing device interoperability, and expanding applications across emerging health concerns. Companies are recommended to invest in partnerships with tech firms and healthcare providers to leverage data analytics and improve device accessibility.

However, challenges such as high development costs, data privacy issues, and regulatory hurdles may impede growth. Market penetration also suffers from resistance to technological adoption among some patient populations and healthcare professionals, alongside concerns about device reliability and lifetime. Innovation should focus on improving the accuracy and integration capabilities of these devices and developing adaptive algorithms that ensure more precise dosing and patient feedback loops.

Furthermore, emphasizing cybersecurity measures to safeguard patient data will be crucial. Innovations in miniaturization and battery life extension may drive competitive differentiation. The market is characterized by a fast-paced technological evolution, requiring continuous adaptation and resilience from stakeholders. Understanding patient needs, regulatory landscapes, and technological advancements are vital to maintaining a sustainable growth trajectory in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of chronic diseases and disorders across the world
  • Supportive regulatory approvals for connected drug delivery devices
  • Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
• Market Restraints
  • Complexities in the accuracy and efficacy of connected drug delivery devices
• Market Opportunities
  • Ongoing innovations to improve the safety and functionality of connected drug delivery devices
  • Potential for the adoption of connected drug delivery devices for personalized medicine
• Market Challenges
  • Privacy concerns and data security issues associated with the usage of connected drug delivery devices

Porter's Five Forces: A Strategic Tool for Navigating the Connected Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Connected Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Connected Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Connected Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Connected Drug Delivery Devices Market

A detailed market share analysis in the Connected Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Connected Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Connected Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Connected Drug Delivery Devices Market

A strategic analysis of the Connected Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Connected Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adherium Limited, AptarGroup, Inc., Becton, Dickinson, and Company, Cognita Labs LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, Findair Sp. z o. o., Gerresheimer AG, Medtronic PLC, Merck KGaA, Molex LLC, Novartis AG, Novo Nordisk A/S, OPKO Health, Inc., Otsuka America, Inc., Presspart Verwaltungs-GmbH, ResMed Inc., SHL Medical AG, Sulzer Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., West Pharmaceutical Services, Inc., Ypsomed Holding, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Connected Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Connected Injection Devices, Smart Inhalers, and Smart Pills.
• Based on Technology, market is studied across Bluetooth, Near Field Communication, and Wi-Fi.
• Based on Therapy Area, market is studied across Cardiovascular Diseases, Diabetes, Neurology, and Respiratory Diseases.
• Based on Distribution Channel, market is studied across Hospitals & Clinical Pharmacies, Online Platforms, and Pharmacies.
• Based on End User, market is studied across Homecare Settings, Hospitals & Clinics, and Research & Development Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of chronic diseases and disorders across the world
    • 5.1.1.2. Supportive regulatory approvals for connected drug delivery devices
    • 5.1.1.3. Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in the accuracy and efficacy of connected drug delivery devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations to improve the safety and functionality of connected drug delivery devices
    • 5.1.3.2. Potential for the adoption of connected drug delivery devices for personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Privacy concerns and data security issues associated with the usage of connected drug delivery devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging advancements and innovations in smart inhalers
  • 5.2.2. Therapy Area: Need for connected drug delivery devices to facilitate real-time monitoring of respiratory diseases
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Connected Drug Delivery Devices Market, by Product

• 6.1. Introduction
• 6.2. Connected Injection Devices
• 6.3. Smart Inhalers
• 6.4. Smart Pills

7. Connected Drug Delivery Devices Market, by Technology

• 7.1. Introduction
• 7.2. Bluetooth
• 7.3. Near Field Communication
• 7.4. Wi-Fi

8. Connected Drug Delivery Devices Market, by Therapy Area

• 8.1. Introduction
• 8.2. Cardiovascular Diseases
• 8.3. Diabetes
• 8.4. Neurology
• 8.5. Respiratory Diseases

9. Connected Drug Delivery Devices Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospitals & Clinical Pharmacies
• 9.3. Online Platforms
• 9.4. Pharmacies

10. Connected Drug Delivery Devices Market, by End User

• 10.1. Introduction
• 10.2. Homecare Settings
• 10.3. Hospitals & Clinics
• 10.4. Research & Development Centers

11. Americas Connected Drug Delivery Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Connected Drug Delivery Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Connected Drug Delivery Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Aptar Digital Health and SHL Medical Collaborate to Enhance Patient Experience with Self-Injectable Drug Delivery Devices
  • 14.3.2. Adherium's Smartinhaler Approved for Use with AstraZeneca Devices, Enhancing Connected Drug Delivery
  • 14.3.3. New Partnership Launches Smart Devices for Tailored Asthma and COPD Care
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Adherium Limited
• 3. AptarGroup, Inc.
• 4. Becton, Dickinson, and Company
• 5. Cognita Labs LLC
• 6. Eli Lilly and Company
• 7. F. Hoffmann-La Roche AG
• 8. Findair Sp. z o. o.
• 9. Gerresheimer AG
• 10. Medtronic PLC
• 11. Merck KGaA
• 12. Molex LLC
• 13. Novartis AG
• 14. Novo Nordisk A/S
• 15. OPKO Health, Inc.
• 16. Otsuka America, Inc.
• 17. Presspart Verwaltungs-GmbH
• 18. ResMed Inc.
• 19. SHL Medical AG
• 20. Sulzer Ltd.
• 21. Teva Pharmaceutical Industries Ltd.
• 22. Viatris Inc.
• 23. West Pharmaceutical Services, Inc.
• 24. Ypsomed Holding
• 25. Zimmer Biomet Holdings, Inc.